{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:04:17Z","timestamp":1784246657001,"version":"3.55.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Struct Mol Biol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41594-022-00837-0","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T15:05:44Z","timestamp":1665587144000},"page":"978-989","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Global, in situ analysis of the structural proteome in individuals with Parkinson\u2019s disease to identify a new class of biomarker"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2928-1144","authenticated-orcid":false,"given":"Marie-Therese","family":"Mackmull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luise","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Sesterhenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2320-5829","authenticated-orcid":false,"given":"Jan","family":"Muntel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9394-5665","authenticated-orcid":false,"given":"Jan","family":"Grossbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Stalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Bruderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma D. J.","family":"van de Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3891-2123","authenticated-orcid":false,"given":"Andreas","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4109-3552","authenticated-orcid":false,"given":"Paola","family":"Picotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"837_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","volume":"159","author":"BK Kennedy","year":"2014","unstructured":"Kennedy, B. K. et al. Geroscience: linking aging to chronic disease. Cell 159, 709\u2013713 (2014).","journal-title":"Cell"},{"key":"837_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/jnc.14635","volume":"151","author":"EM Cilento","year":"2019","unstructured":"Cilento, E. M. et al. Mass spectrometry: a platform for biomarker discovery and validation for Alzheimer\u2019s and Parkinson\u2019s diseases. J. Neurochem. 151, 397\u2013416 (2019).","journal-title":"J. Neurochem."},{"key":"837_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-015-9102-9","volume":"13","author":"CA Crutchfield","year":"2016","unstructured":"Crutchfield, C. A., Thomas, S. N., Sokoll, L. J. & Chan, D. W. Advances in mass spectrometry-based clinical biomarker discovery. Clin. Proteom. 13, 1 (2016).","journal-title":"Clin. Proteom."},{"key":"837_CR4","doi-asserted-by":"publisher","first-page":"e17478","DOI":"10.1097\/MD.0000000000017478","volume":"98","author":"R Jiang","year":"2019","unstructured":"Jiang, R. et al. Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease. Medicine 98, e17478 (2019).","journal-title":"Medicine"},{"key":"837_CR5","doi-asserted-by":"crossref","unstructured":"Macklin, A., Khan, S. & Kislinger, T. Recent advances in mass spectrometry based clinical proteomics: applications to cancer research. Clin. Proteomics 17, 17 (2020).","DOI":"10.1186\/s12014-020-09283-w"},{"key":"837_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/14789450.2018.1433036","volume":"15","author":"C Thygesen","year":"2018","unstructured":"Thygesen, C., Boll, I., Finsen, B., Modzel, M. & Larsen, M. R. Characterizing disease-associated changes in post-translational modifications by mass spectrometry. Expert Rev. Proteom. 15, 245\u2013258 (2018).","journal-title":"Expert Rev. Proteom."},{"key":"837_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature11271","volume":"488","author":"SR Tzeng","year":"2012","unstructured":"Tzeng, S. R. & Kalodimos, C. G. Protein activity regulation by conformational entropy. Nature 488, 236\u2013240 (2012).","journal-title":"Nature"},{"key":"837_CR8","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/nature06522","volume":"450","author":"K Henzler-Wildman","year":"2007","unstructured":"Henzler-Wildman, K. & Kern, D. Dynamic personalities of proteins. Nature 450, 964\u2013972 (2007).","journal-title":"Nature"},{"key":"837_CR9","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1038\/nprot.2017.100","volume":"12","author":"S Schopper","year":"2017","unstructured":"Schopper, S. et al. Measuring protein structural changes on a proteome-wide scale using limited proteolysis-coupled mass spectrometry. Nat. Protoc. 12, 2391\u20132410 (2017).","journal-title":"Nat. Protoc."},{"key":"837_CR10","doi-asserted-by":"crossref","unstructured":"Feng, Y. et al. Global analysis of protein structural changes in complex proteomes. Nat. Biotechnol. 32, 1036\u20131044(2014).","DOI":"10.1038\/nbt.2999"},{"key":"837_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2020.12.021","volume":"184","author":"V Cappelletti","year":"2021","unstructured":"Cappelletti, V. et al. Dynamic 3D proteomes reveal protein functional alterations at high resolution in situ. Cell 184, 545\u2013559.e22 (2021).","journal-title":"Cell"},{"key":"837_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. \u03b1-synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"837_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"837_CR14","doi-asserted-by":"crossref","unstructured":"Br\u00e1s, I. C., Xylaki, M. & Outeiro, T. F. Mechanisms of alpha-synuclein toxicity: an update and outlook. Prog. Brain. Res. 252, 91\u2013129 (2020).","DOI":"10.1016\/bs.pbr.2019.10.005"},{"key":"837_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.mcn.2018.12.005","volume":"97","author":"F Maass","year":"2019","unstructured":"Maass, F., Schulz, I., Lingor, P., Mollenhauer, B. & B\u00e4hr, M. Cerebrospinal fluid biomarker for Parkinson\u2019s disease: an overview. Mol. Cell. Neurosci. 97, 60\u201366 (2019).","journal-title":"Mol. Cell. Neurosci."},{"key":"837_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ejn.13760","volume":"47","author":"G Borrageiro","year":"2018","unstructured":"Borrageiro, G., Haylett, W., Seedat, S., Kuivaniemi, H. & Bardien, S. A review of genome-wide transcriptomics studies in Parkinson\u2019s disease. Eur. J. Neurosci. 47, 1\u201316 (2018).","journal-title":"Eur. J. Neurosci."},{"key":"837_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-016-0072-9","volume":"11","author":"NK Majbour","year":"2016","unstructured":"Majbour, N. K. et al. Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson\u2019s disease. Mol. Neurodegener. 11, 7 (2016).","journal-title":"Mol. Neurodegener."},{"key":"837_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","volume":"18","author":"L Parnetti","year":"2019","unstructured":"Parnetti, L. et al. CSF and blood biomarkers for Parkinson\u2019s disease. Lancet Neurol. 18, 573\u2013586 (2019).","journal-title":"Lancet Neurol."},{"key":"837_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/mds.25495","volume":"28","author":"KD van Dijk","year":"2013","unstructured":"van Dijk, K. D. et al. Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson\u2019s disease. Mov. Disord. 28, 747\u2013754 (2013).","journal-title":"Mov. Disord."},{"key":"837_CR20","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1002\/mds.111","volume":"33","author":"I van Steenoven","year":"2018","unstructured":"van Steenoven, I. et al. \u03b1-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies. Mov. Disord. 33, 1724\u20131733 (2018).","journal-title":"Mov. Disord."},{"key":"837_CR21","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.parkreldis.2013.07.016","volume":"19","author":"KD Van Dijk","year":"2013","unstructured":"Van Dijk, K. D. et al. Cerebrospinal fluid and plasma clusterin levels in Parkinson\u2019s disease. Park. Relat. Disord. 19, 1079\u20131083 (2013).","journal-title":"Park. Relat. Disord."},{"key":"837_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/ene.12176","volume":"21","author":"KD van Dijk","year":"2014","unstructured":"van Dijk, K. D. et al. Reduced \u03b1-synuclein levels in cerebrospinal fluid in Parkinson\u2019s disease are unrelated to clinical and imaging measures of disease severity. Eur. J. Neurol. 21, 388\u2013394 (2014).","journal-title":"Eur. J. Neurol."},{"key":"837_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fnagi.2021.638718","volume":"13","author":"IY Abdi","year":"2021","unstructured":"Abdi, I. Y. et al. Preanalytical stability of CSF total and oligomeric \u03b1-synuclein. Front. Aging Neurosci. 13, 85 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"837_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OMA El\u2010Agnaf","year":"2006","unstructured":"El\u2010Agnaf, O. M. A. et al. Detection of oligomeric forms of \u03b1\u2010synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. FASEB J. 20, 419\u2013425 (2006).","journal-title":"FASEB J."},{"key":"837_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21228519","volume":"21","author":"LP Oosterveld","year":"2020","unstructured":"Oosterveld, L. P. et al. CSF biomarkers reflecting protein pathology and axonal degeneration are associated with memory, attentional, and executive functioning in early-stage Parkinson\u2032s disease. Int. J. Mol. Sci. 21, 1\u201312 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"837_CR26","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1021\/acs.jproteome.8b00300","volume":"17","author":"C Macron","year":"2018","unstructured":"Macron, C., Lane, L., N\u00fanez Galindo, A. & Dayon, L. Deep dive on the proteome of human cerebrospinal fluid: a valuable data resource for biomarker discovery and missing protein identification. J. Proteome Res. 17, 4113\u20134126 (2018).","journal-title":"J. Proteome Res."},{"key":"837_CR27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/cells9020370","volume":"9","author":"Barkovits","year":"2020","unstructured":"Barkovits et al. Blood contamination in CSF and its impact on quantitative analysis of \u03b1-synuclein. Cells 9, 370 (2020).","journal-title":"Cells"},{"key":"837_CR28","doi-asserted-by":"publisher","first-page":"105704","DOI":"10.1016\/j.dib.2020.105704","volume":"31","author":"C Macron","year":"2020","unstructured":"Macron, C. et al. Exploration of human cerebrospinal fluid: a large proteome dataset revealed by trapped ion mobility time-of-flight mass spectrometry. Data Brief 31, 105704 (2020).","journal-title":"Data Brief"},{"key":"837_CR29","doi-asserted-by":"publisher","first-page":"i343","DOI":"10.1093\/bioinformatics\/btz324","volume":"35","author":"J Zhang","year":"2019","unstructured":"Zhang, J. & Kurgan, L. SCRIBER: accurate and partner type-specific prediction of protein-binding residues from proteins sequences. Bioinformatics 35, i343\u2013i353 (2019).","journal-title":"Bioinformatics"},{"key":"837_CR30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/bioinformatics\/btu744","volume":"31","author":"DT Jones","year":"2015","unstructured":"Jones, D. T. & Cozzetto, D. DISOPRED3: precise disordered region predictions with annotated protein-binding activity. Bioinformatics 31, 857\u2013863 (2015).","journal-title":"Bioinformatics"},{"key":"837_CR31","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1212\/WNL.0000000000001332","volume":"84","author":"GW Beecham","year":"2015","unstructured":"Beecham, G. W. et al. PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology 84, 972\u2013980 (2015).","journal-title":"Neurology"},{"key":"837_CR32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"837_CR33","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ng.3955","volume":"2017","author":"D Chang","year":"2017","unstructured":"Chang, D. et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci. Nat. Genet. 2017, 1511\u20131516 (2017).","journal-title":"Nat. Genet."},{"key":"837_CR34","first-page":"35","volume":"8","author":"E Hoxha","year":"2016","unstructured":"Hoxha, E., Tempia, F., Lippiello, P. & Miniaci, M. C. Modulation, plasticity and pathophysiology of the parallel fiber-purkinje cell synapse. Front. Synaptic. Neurosci. 8, 35 (2016).","journal-title":"Neurosci."},{"key":"837_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-03802-y","volume":"9","author":"N Lozovaya","year":"2018","unstructured":"Lozovaya, N. et al. GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease. Nat. Commun. 9, 1\u201314 (2018).","journal-title":"Nat. Commun."},{"key":"837_CR36","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s11064-019-02739-y","volume":"44","author":"X Zheng","year":"2019","unstructured":"Zheng, X. et al. Increase in glutamatergic terminals in the striatum following dopamine depletion in a rat model of Parkinson\u2019s disease. Neurochem. Res. 44, 1079\u20131089 (2019).","journal-title":"Neurochem. Res."},{"key":"837_CR37","doi-asserted-by":"crossref","unstructured":"Gardoni, F., Ghiglieri, V., Luca, M. di & Calabresi, P. Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson\u2019s disease. Prog. Brain Res. 183, 169\u2013182 (2010).","DOI":"10.1016\/S0079-6123(10)83009-2"},{"key":"837_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fnins.2016.00269","volume":"10","author":"JW B\u0142aszczyk","year":"2016","unstructured":"B\u0142aszczyk, J. W. Parkinson\u2019s disease and neurodegeneration: GABA-collapse hypothesis. Front. Neurosci. 10, 269 (2016).","journal-title":"Front. Neurosci."},{"key":"837_CR39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fncel.2013.00286","volume":"7","author":"M Kayakabe","year":"2014","unstructured":"Kayakabe, M. et al. Motor dysfunction in cerebellar Purkinje cell-specific vesicular GABA transporter knockout mice. Front. Cell. Neurosci. 7, 286 (2014).","journal-title":"Front. Cell. Neurosci."},{"key":"837_CR40","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3389\/fphar.2019.01294","volume":"10","author":"A Murueta-Goyena","year":"2019","unstructured":"Murueta-Goyena, A., Andikoetxea, A., G\u00f3mez-Esteban, J. C. & Gabilondo, I. Contribution of the GABAergic system to non-motor manifestations in premotor and early stages of Parkinson\u2019s disease. Front. Pharmacol. 10, 1294 (2019).","journal-title":"Front. Pharmacol."},{"key":"837_CR41","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbrc.2016.08.168","volume":"483","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier, D. J. et al. Calcium and Parkinson\u2019s disease. Biochem. Biophys. Res. Commun. 483, 1013\u20131019 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"837_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ceca.2017.06.008","volume":"70","author":"E Pchitskaya","year":"2018","unstructured":"Pchitskaya, E., Popugaeva, E. & Bezprozvanny, I. Calcium signaling and molecular mechanisms underlying neurodegenerative diseases. Cell Calcium 70, 87\u201394 (2018).","journal-title":"Cell Calcium"},{"key":"837_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-10-98","volume":"10","author":"JC Latourelle","year":"2009","unstructured":"Latourelle, J. C. et al. Genomewide association study for onset age in Parkinson disease. BMC Med. Genet. 10, 98 (2009).","journal-title":"BMC Med. Genet."},{"key":"837_CR44","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mds.27659","volume":"34","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat, C. et al. Parkinson\u2019s disease age at onset genome-wide association study: defining heritability, genetic loci, and \u03b1-synuclein mechanisms. Mov. Disord. 34, 866\u2013875 (2019).","journal-title":"Mov. Disord."},{"key":"837_CR45","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mds.28342","volume":"36","author":"MMX Tan","year":"2021","unstructured":"Tan, M. M. X. et al. Genome-wide association studies of cognitive and motor progression in Parkinson\u2019s disease. Mov. Disord. 36, 424\u2013433 (2021).","journal-title":"Mov. Disord."},{"key":"837_CR46","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.ajpath.2011.07.021","volume":"179","author":"MMM Wilhelmus","year":"2011","unstructured":"Wilhelmus, M. M. M. et al. Short communication apolipoprotein E and LRP1 increase early in Parkinson\u2019s disease pathogenesis. Am. J. Pathol. 179, 2152\u20132156 (2011).","journal-title":"Am. J. Pathol."},{"key":"837_CR47","doi-asserted-by":"crossref","unstructured":"Troy T, R. & Jacob M, M. Apolipoprotein E fragmentation within lewy bodies of the human Parkinson\u2019s disease brain. Int. J. Neurodegener. Disord. 1, 002 (2018).","DOI":"10.23937\/ijnd-2017\/1710002"},{"key":"837_CR48","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.neuron.2007.05.004","volume":"54","author":"J Xu","year":"2007","unstructured":"Xu, J., Mashimo, T. & S\u00fcdhof, T. C. Synaptotagmin-1, -2, and -9: Ca2+ sensors for fast release that specify distinct presynaptic properties in subsets of neurons. Neuron 54, 567\u2013581 (2007).","journal-title":"Neuron"},{"key":"837_CR49","doi-asserted-by":"publisher","unstructured":"Delignat-Lavaud, B. et al. The calcium sensor synaptotagmin-1 is critical for phasic axonal dopamine release in the striatum and mesencephalon, but is dispensable for basic motor behaviors in mice. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.09.15.460511 (2021).","DOI":"10.1101\/2021.09.15.460511"},{"key":"837_CR50","doi-asserted-by":"publisher","first-page":"24509","DOI":"10.1074\/jbc.M115.647248","volume":"290","author":"M Wu","year":"2015","unstructured":"Wu, M., Puddifoot, C. A., Taylor, P. & Joiner, W. J. Mechanisms of inhibition and potentiation of \u03b14\u03b22 nicotinic acetylcholine receptors by members of the Ly6 protein family. J. Biol. Chem. 290, 24509 (2015).","journal-title":"J. Biol. Chem."},{"key":"837_CR51","first-page":"1","volume":"2019","author":"Q Wang","year":"2019","unstructured":"Wang, Q. et al. The landscape of multiscale transcriptomic networks and key regulators in Parkinson\u2019s disease. Nat. Commun. 2019, 1\u201315 (2019). 101 10.","journal-title":"Nat. Commun."},{"key":"837_CR52","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0002-9440(10)64249-6","volume":"161","author":"JHT Power","year":"2002","unstructured":"Power, J. H. T., Shannon, J. M., Blumbergs, P. C. & Gai, W. P. Nonselenium glutathione peroxidase in human brain: elevated levels in Parkinson\u2019s disease and dementia with Lewy bodies. Am. J. Pathol. 161, 885\u2013894 (2002).","journal-title":"Am. J. Pathol."},{"key":"837_CR53","doi-asserted-by":"crossref","unstructured":"Corradini, B. R. et al. Complex network-driven view of genomic mechanisms underlying Parkinson\u2019s disease: Analyses in dorsal motor vagal nucleus, locus coeruleus, and substantia nigra. Biomed. Res. Int. 543673 (2014).","DOI":"10.1155\/2014\/543673"},{"key":"837_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2018.09.018","volume":"73","author":"M Lach\u00e9n-Montes","year":"2019","unstructured":"Lach\u00e9n-Montes, M. et al. Unveiling the olfactory proteostatic disarrangement in Parkinson\u2019s disease by proteome-wide profiling. Neurobiol. Aging 73, 123\u2013134 (2019).","journal-title":"Neurobiol. Aging"},{"key":"837_CR55","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1021\/acs.jproteome.0c00452","volume":"19","author":"M Lach\u00e9n-Montes","year":"2020","unstructured":"Lach\u00e9n-Montes, M. et al. Smelling the dark proteome: functional characterization of PITH domain-containing protein 1 (C1orf128) in olfactory metabolism. J. Proteome Res. 19, 4826\u20134843 (2020).","journal-title":"J. Proteome Res."},{"key":"837_CR56","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1089\/ars.2015.6336","volume":"24","author":"S Ma","year":"2016","unstructured":"Ma, S. et al. Peroxiredoxin 6 is a crucial factor in the initial step of mitochondrial clearance and is upstream of the PINK1\u2013parkin pathway. Antioxid. Redox Signal. 24, 486\u2013501 (2016).","journal-title":"Antioxid. Redox Signal."},{"key":"837_CR57","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s12035-014-8885-4","volume":"52","author":"HM Yun","year":"2015","unstructured":"Yun, H. M., Choi, D. Y., Oh, K. W. & Hong, J. T. PRDX6 exacerbates dopaminergic neurodegeneration in a MPTP mouse model of Parkinson\u2019s disease. Mol. Neurobiol. 52, 422\u2013431 (2015).","journal-title":"Mol. Neurobiol."},{"key":"837_CR58","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.aae0104","volume":"353","author":"J Elegheert","year":"2016","unstructured":"Elegheert, J. et al. Structural basis for integration of GluD receptors within synaptic organizer complexes. Science 353, 295\u2013300 (2016).","journal-title":"Science"},{"key":"837_CR59","doi-asserted-by":"crossref","unstructured":"Chipman, P. & Goda, Y in Dendrites: Development and Disease 425\u2013465 (Springer Japan, 2016).","DOI":"10.1007\/978-4-431-56050-0_17"},{"key":"837_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.sbi.2019.01.010","volume":"54","author":"SY Won","year":"2019","unstructured":"Won, S. Y., Lee, P. & Kim, H. M. Synaptic organizer: Slitrks and type IIa receptor protein tyrosine phosphatasess. Curr. Opin. Struct. Biol. 54, 95\u2013103 (2019).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"837_CR61","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1523\/JNEUROSCI.2768-16.2016","volume":"37","author":"SJ Lee","year":"2017","unstructured":"Lee, S. J. et al. Presynaptic neuronal pentraxin receptor organizes excitatory and inhibitory synapses. J. Neurosci. 37, 1062\u20131080 (2017).","journal-title":"J. Neurosci."},{"key":"837_CR62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/ijms20010141","volume":"20","author":"F Longhena","year":"2019","unstructured":"Longhena, F., Faustini, G., Spillantini, M. G. & Bellucci, A. Living in promiscuity: the multiple partners of \u03b1-synuclein at the synapse in physiology and pathology. Int. J. Mol. Sci. 20, 141 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"837_CR63","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/fneur.2020.00454","volume":"11","author":"ME Fullard","year":"2020","unstructured":"Fullard, M. E. & Duda, J. E. A review of the relationship between vitamin D and Parkinson disease symptoms. Front. Neurol. 11, 454 (2020).","journal-title":"Front. Neurol."},{"key":"837_CR64","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/mds.27888","volume":"35","author":"M Lawton","year":"2020","unstructured":"Lawton, M. et al. Blood biomarkers with Parkinson\u2019s disease clusters and prognosis: the oxford discovery cohort. Mov. Disord. 35, 279\u2013287 (2020).","journal-title":"Mov. Disord."},{"key":"837_CR65","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-019-00433-1","volume":"36","author":"T Li","year":"2020","unstructured":"Li, T. & Le, W. Biomarkers for Parkinson\u2019s disease: how good are they? Neurosci. Bull. 36, 183\u2013194 (2020).","journal-title":"Neurosci. Bull."},{"key":"837_CR66","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/mds.27646","volume":"34","author":"UJ Kang","year":"2019","unstructured":"Kang, U. J. et al. Comparative study of cerebrospinal fluid \u03b1-synuclein seeding aggregation assays for diagnosis of Parkinson\u2019s disease. Mov. Disord. 34, 536\u2013544 (2019).","journal-title":"Mov. Disord."},{"key":"837_CR67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi, M. et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 140, 49\u201362 (2020).","journal-title":"Acta Neuropathol."},{"key":"837_CR68","first-page":"1","volume":"2020","author":"MS Rotunno","year":"2020","unstructured":"Rotunno, M. S. et al. Cerebrospinal fluid proteomics implicates the granin family in Parkinson\u2019s disease. Sci. Rep. 2020, 1\u201311 (2020).","journal-title":"Sci. Rep."},{"key":"837_CR69","doi-asserted-by":"publisher","first-page":"e018177","DOI":"10.1136\/bmjopen-2017-018177","volume":"7","author":"P Eusebi","year":"2017","unstructured":"Eusebi, P. et al. Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson\u2019s disease: protocol for a systematic review and individual participant data meta-analysis. BMJ Open 7, e018177 (2017).","journal-title":"BMJ Open"},{"key":"837_CR70","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.conb.2019.11.019","volume":"61","author":"J Simr\u00e9n","year":"2020","unstructured":"Simr\u00e9n, J., Ashton, N. J., Blennow, K. & Zetterberg, H. An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead. Curr. Opin. Neurobiol. 61, 29\u201339 (2020).","journal-title":"Curr. Opin. Neurobiol."},{"key":"837_CR71","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10571-019-00700-9","volume":"39","author":"A Dixit","year":"2019","unstructured":"Dixit, A., Mehta, R. & Singh, A. K. Proteomics in human Parkinson\u2019s disease: present scenario and future directions. Cell. Mol. Neurobiol. 39, 901\u2013915 (2019).","journal-title":"Cell. Mol. Neurobiol."},{"key":"837_CR72","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cca.2019.04.078","volume":"495","author":"L Parnetti","year":"2019","unstructured":"Parnetti, L. et al. Parkinson\u2019s and Lewy body dementia CSF biomarkers. Clin. Chim. Acta 495, 318\u2013325 (2019).","journal-title":"Clin. Chim. Acta"},{"key":"837_CR73","doi-asserted-by":"crossref","unstructured":"Heywood, W. E. et al. Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay. Mol. Neurodegener. 10, 64 (2015).","DOI":"10.1186\/s13024-015-0059-y"},{"key":"837_CR74","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2017.01.016","volume":"37","author":"NK Magdalinou","year":"2017","unstructured":"Magdalinou, N. K. et al. Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics. Parkinsonism Relat. Disord. 37, 65\u201371 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"837_CR75","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/jnnp-2013-307539","volume":"85","author":"N Magdalinou","year":"2014","unstructured":"Magdalinou, N., Lees, A. J. & Zetterberg, H. Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions. J. Neurol. Neurosurg. Psychiatry 85, 1065\u20131075 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"837_CR76","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s12640-019-00080-4","volume":"36","author":"A Sarkar","year":"2019","unstructured":"Sarkar, A., Rawat, N., Sachan, N. & Singh, M. P. Unequivocal biomarker for Parkinson\u2019s disease: a hunt that remains a pester. Neurotox. Res. 36, 627\u2013644 (2019).","journal-title":"Neurotox. Res."},{"key":"837_CR77","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fnmol.2019.00240","volume":"12","author":"W Liu","year":"2019","unstructured":"Liu, W. et al. Role of exosomes in central nervous system diseases. Front. Mol. Neurosci. 12, 240 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"837_CR78","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"837_CR79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40478-020-00914-9","volume":"8","author":"H Geut","year":"2020","unstructured":"Geut, H. et al. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series. Acta Neuropathol. Commun. 8, 39 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"837_CR80","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: aclinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181\u2013184 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"837_CR81","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn, M. M. & Yahr, M. D. Parkinsonism: onset, progression, and mortality. Neurology 17, 427\u2013442 (1967).","journal-title":"Neurology"},{"key":"837_CR82","unstructured":"Fahn, S. et al. The Unified Parkinson\u2019s Disease Rating Scale. In Fahn, S. et al. (eds.) Recent Developments in Parkinson\u2019s Disease, Vol. 2, 153-163 (1987)."},{"key":"837_CR83","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1192\/bjp.149.6.698","volume":"149","author":"M Roth","year":"1986","unstructured":"Roth, M. et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry 149, 698\u2013709 (1986).","journal-title":"Br. J. Psychiatry"},{"key":"837_CR84","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00401-009-0523-2","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff, I. et al. Staging\/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol. 117, 635\u2013652 (2009).","journal-title":"Acta Neuropathol."},{"key":"837_CR85","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","volume":"59","author":"DR Thal","year":"2000","unstructured":"Thal, D. R. et al. Sequence of A\u03b2-protein deposition in the human medial temporal lobe. J. Neuropathol. Exp. Neurol. 59, 733\u2013748 (2000).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"837_CR86","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","volume":"18","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff, I. et al. Staging of neurofibrillary pathology in Alzheimer\u2019s disease: a study of the BrainNet Europe Consortium. Brain Pathol. 18, 484\u2013496 (2008).","journal-title":"Brain Pathol."},{"key":"837_CR87","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra, S. S. et al. The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41, 479\u2013486 (1991).","journal-title":"Neurology"},{"key":"837_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine, T. J. et al. National institute on aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 123, 1\u201311 (2012).","journal-title":"Acta Neuropathol."},{"key":"837_CR89","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","volume":"115","author":"DR Thal","year":"2008","unstructured":"Thal, D. R., Griffin, W. S. T., de Vos, R. A. I. & Ghebremedhin, E. Cerebral amyloid angiopathy and its relationship to Alzheimer\u2019s disease. Acta Neuropathol. 115, 599\u2013609 (2008).","journal-title":"Acta Neuropathol."},{"key":"837_CR90","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs, G. G. et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol. 131, 87\u2013102 (2016).","journal-title":"Acta Neuropathol."},{"key":"837_CR91","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen, C. E. et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 73, 1914\u20131922 (2009).","journal-title":"Neurology"},{"key":"837_CR92","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1074\/mcp.RA117.000314","volume":"16","author":"R Bruderer","year":"2017","unstructured":"Bruderer, R. et al. Optimization of experimental parameters in data-independent mass spectrometry significantly increases depth and reproducibility of results. Mol. Cell. Proteom. 16, 2296\u20132309 (2017).","journal-title":"Mol. Cell. Proteom."},{"key":"837_CR93","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1074\/mcp.M900317-MCP200","volume":"8","author":"L Reiter","year":"2009","unstructured":"Reiter, L. et al. Protein identification false discovery rates for very large proteomics data sets generated by tandem mass spectrometry*. Mol. Cell. Proteom. 8, 2405\u20132417 (2009).","journal-title":"Mol. Cell. Proteom."},{"key":"837_CR94","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1074\/mcp.M114.046995","volume":"14","author":"MM Savitski","year":"2015","unstructured":"Savitski, M. M., Wilhelm, M., Hahne, H., Kuster, B. & Bantscheff, M. A scalable approach for protein false discovery rate estimation in large proteomic data sets. Mol. Cell. Proteom. 14, 2394\u20132404 (2015).","journal-title":"Mol. Cell. Proteom."},{"key":"837_CR95","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1039\/C9MO00082H","volume":"15","author":"J Muntel","year":"2019","unstructured":"Muntel, J. et al. Surpassing 10,000 identified and quantified proteins in a single run by optimizing current LC\u2013MS instrumentation and data analysis strategy. Mol. Omics 15, 348\u2013360 (2019).","journal-title":"Mol. Omics"},{"key":"837_CR96","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1074\/mcp.M114.044305","volume":"14","author":"R Bruderer","year":"2015","unstructured":"Bruderer, R. et al. Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol. Cell. Proteom. 14, 1400\u20131410 (2015).","journal-title":"Mol. Cell. Proteom."},{"key":"837_CR97","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jprot.2015.09.013","volume":"129","author":"G Teo","year":"2015","unstructured":"Teo, G. et al. MapDIA: preprocessing and statistical analysis of quantitative proteomics data from data independent acquisition mass spectrometry. J. Proteom. 129, 108\u2013120 (2015).","journal-title":"J. Proteom."},{"key":"837_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i03","volume":"28","author":"W Hui","year":"2008","unstructured":"Hui, W., Gel, Y. R. & Gastwirth, J. L. Lawstat: an R package for law, public policy and biostatistics. J. Stat. Softw. 28, 1\u201326 (2008).","journal-title":"J. Stat. Softw."},{"key":"837_CR99","unstructured":"Ameijeiras, J., Rosa, A., Crujeiras, M. & Rodr\u00edguez-Casal, A. multimode: an R package for mode assessment. J. Stat. Softw. 97, 1\u201332 (2018)."},{"key":"837_CR100","doi-asserted-by":"publisher","first-page":"W402","DOI":"10.1093\/nar\/gkz297","volume":"47","author":"DWA Buchan","year":"2019","unstructured":"Buchan, D. W. A. & Jones, D. T. The PSIPRED Protein Analysis Workbench: 20 years on. Nucleic Acids Res. 47, W402\u2013W407 (2019).","journal-title":"Nucleic Acids Res."},{"key":"837_CR101","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12859-019-2796-3","volume":"20","author":"J Bonet","year":"2019","unstructured":"Bonet, J., Harteveld, Z., Sesterhenn, F., Scheck, A. & Correia, B. E. Rstoolbox\u2014a Python library for large-scale analysis of computational protein design data and structural bioinformatics. BMC Bioinform. 20, 240 (2019).","journal-title":"BMC Bioinform."},{"key":"837_CR102","doi-asserted-by":"publisher","first-page":"D298","DOI":"10.1093\/nar\/gkaa931","volume":"49","author":"B Zhao","year":"2021","unstructured":"Zhao, B. et al. DescribePROT: database of amino acid-level protein structure and function predictions. Nucleic Acids Res. 49, D298\u2013D308 (2021).","journal-title":"Nucleic Acids Res."},{"key":"837_CR103","doi-asserted-by":"crossref","unstructured":"Peng, K., Radivojac, P., Vucetic, S., Dunker, A. K. & Obradovic, Z. Length-dependent prediction of protein intrinsic disorder. BMC Bioinform. 7, 208 (2006).","DOI":"10.1186\/1471-2105-7-208"},{"key":"837_CR104","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1002\/prot.24682","volume":"82","author":"E Faraggi","year":"2014","unstructured":"Faraggi, E., Zhou, Y. & Kloczkowski, A. Accurate single-sequence prediction of solvent accessible surface area using local and global features. Proteins 82, 3170\u20133176 (2014).","journal-title":"Proteins"},{"key":"837_CR105","first-page":"e84","volume":"45","author":"J Yan","year":"2017","unstructured":"Yan, J. & Kurgan, L. DRNApred, fast sequence-based method that accurately predicts and discriminates DNA-and RNA-binding residues. Nucleic Acids Res. 45, e84 (2017).","journal-title":"Nucleic Acids Res."},{"key":"837_CR106","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613 (2019).","journal-title":"Nucleic Acids Res."},{"key":"837_CR107","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"837_CR108","unstructured":"Alexa, A. & Rahnenfuhrer, J. topGO: Enrichment analysis for gene ontology. Bioconductor R package (2020)."},{"key":"837_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"key":"837_CR110","doi-asserted-by":"crossref","unstructured":"Quast, J.-P., Schuster, D. & Picotti, P. protti: an R package for comprehensive data analysis of peptide- and protein-centric bottom-up proteomics data. Bioinform. Adv. 2, 1 (2022).","DOI":"10.1093\/bioadv\/vbab041"},{"key":"837_CR111","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."},{"key":"837_CR112","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.clinbiochem.2011.01.002","volume":"44","author":"HM Chen","year":"2011","unstructured":"Chen, H. M., Lin, C. Y. & Wang, V. Amyloid P component as a plasma marker for Parkinson\u2019s disease identified by a proteomic approach. Clin. Biochem. 44, 377\u2013385 (2011).","journal-title":"Clin. Biochem."},{"key":"837_CR113","doi-asserted-by":"crossref","unstructured":"Dong, M. X. et al. Serum butyrylcholinesterase activity: A biomarker for Parkinson\u2019s disease and related dementia. Biomed Res. Int. 2017, 1524107 (2017).","DOI":"10.1155\/2017\/1524107"}],"container-title":["Nature Structural & Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41594-022-00837-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41594-022-00837-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41594-022-00837-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T20:31:50Z","timestamp":1701203510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41594-022-00837-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":113,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1038\/s41594-022-00837-0","relation":{},"ISSN":["1545-9993","1545-9985"],"issn-type":[{"value":"1545-9993","type":"print"},{"value":"1545-9985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"30 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors RB, JM and LR are full-time employees of Biognosys AG (Zurich, Switzerland). Spectronaut is a trademark of Biognosys AG. PP is an inventor of a patent licensed by Biognosys AG that covers the LiP\u2013MS method used in this manuscript. WvdB performed contract research and consultancy for Hoffmann-La Roche, Roche Tissue Diagnostics, Crossbeta Sciences, Discoveric Bio and received research consumables from Hoffmann-La Roche and Prothena. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}